Advice
Not recommended for use within NHS Scotland.
REASONS FOR ADVICE
Given its higher costs, value for money has not been demonstrated for this product. For patients who may benefit from a combination of corticosteroid and calcipotriol, it may be more appropriate to have independent control over the potency, dosing and duration of corticosteroid used than to use a fixed dose combination involving a very potent steroid.
Download detailed advice18KB (PDF)
Medicine details
- Medicine name:
- Calcipotriol and bethamethasone ointment (Dovobet®)
- SMC ID:
- 09/02
- Indication:
- Stable plaque psoriasis vulgaris amenable to topical therapy
- Pharmaceutical company
- LEO Pharmaceuticals
- BNF chapter
- Skin
- Submission type
- Full
- Status
- Not recommended
- Date advice published
- 06 September 2002